A detailed history of Paragon Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Paragon Capital Management LLC holds 263 shares of LLY stock, worth $207,293. This represents 0.13% of its overall portfolio holdings.

Number of Shares
263
Holding current value
$207,293
% of portfolio
0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$772.14 - $960.02 $203,072 - $252,485
263 New
263 $233,000
Q2 2020

Aug 03, 2020

SELL
$136.42 - $164.18 $22,236 - $26,761
-163 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$119.05 - $147.35 $19,405 - $24,018
163 New
163 $23,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paragon Capital Management LLC Portfolio

Follow Paragon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LLC with notifications on news.